These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11202797)

  • 1. Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma.
    Ono Y; Yoshimasu T; Ashikaga R; Inoue M; Shindou H; Fuji K; Araki Y; Nishimura Y
    Am J Clin Oncol; 2000 Dec; 23(6):564-8. PubMed ID: 11202797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion.
    Kamada K; Nakanishi T; Kitamoto M; Aikata H; Kawakami Y; Ito K; Asahara T; Kajiyama G
    J Vasc Interv Radiol; 2001 Jul; 12(7):847-54. PubMed ID: 11435541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results.
    Nishimine K; Uchida H; Matsuo N; Sakaguchi H; Hirohashi S; Nishimura Y; Guo Q; Ohishi H; Nagano N; Yoshioka T
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S60-8. PubMed ID: 7511069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors.
    Ueno K; Miyazono N; Inoue H; Nishida H; Kanetsuki I; Nakajo M
    Cancer; 2000 Apr; 88(7):1574-81. PubMed ID: 10738215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of chemoembolization therapy for primary liver cancer using a stabilized adriamycin-lipiodol suspension.
    Horiguchi Y; Itoh M; Takagawa H; Imai H; Kamei A; Sekoguchi B; Nagamura Y
    Cancer Chemother Pharmacol; 1992; 31 Suppl():S60-4. PubMed ID: 1333909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Lipiodol in transcatheter arterial embolization of hepatocellular carcinoma.
    Nakao N; Uchida H; Kamino K; Nishimura Y; Ohishi H; Takayasu Y; Nakamura H; Kuroda C; Fujita M; Yoshioka H
    Cancer Chemother Pharmacol; 1992; 31 Suppl():S72-6. PubMed ID: 1333913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinostatin stimalamer-transcatheter arterial embolization for hepatocellular carcinoma: a comparison with lipiodol-transcatheter arterial embolization.
    Hirashima N; Sakakibara K; Itazu I; Hirai T; Nemoto A; Matsuura H; Kumada K; Nojiri O; Kano H
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-91-S6-96. PubMed ID: 9151922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy consisting of arterial infusion chemotherapy (EPF, EAP) and transcatheter arterial embolization (TAE).
    Yodono H; Takekawa SD; Tarusawa K; Ikami I; Kanehira J; Saito Y; Takahashi S; Sasaki T; Nishi N; Kimura T
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S79-83. PubMed ID: 8137489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the optimum dose level of lipiodol in transcatheter arterial embolization of primary hepatocellular carcinoma based on retrospective multivariate analysis.
    Nakao N; Uchida H; Kamino K; Nishimura Y; Ohishi H; Takayasu Y; Miura K
    Cardiovasc Intervent Radiol; 1994; 17(2):76-80. PubMed ID: 8013027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and toxicity of transcatheter arterial chemoembolization with Cisplatin suspended in lipiodol for unresectable hepatocellular carcinoma].
    Uyama N; Hatano E; Maetani Y; Isoda H; Shibata T; Taura K; Oe S; Naito M; Yasuchika K; Fujii H; Ikai I; Uemoto S
    Gan To Kagaku Ryoho; 2008 May; 35(5):775-80. PubMed ID: 18487912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Behavior of anti-cancer drug of transcatheter hepatic segmental arterial chemoembolization using lipiodol mixed with an anti-cancer drug followed by gelatin sponge assessed by Tc-99m pertechnetate].
    Sakaguchi H; Yoshimura H; Nishimura Y; Iwata K; Ohishi H; Uchida H
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1725-30. PubMed ID: 2167644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis.
    Tanaka K; Nakamura S; Numata K; Kondo M; Morita K; Kitamura T; Saito S; Kiba T; Okazaki H; Sekihara H
    Cancer; 1998 Jan; 82(1):78-85. PubMed ID: 9428482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter arterial chemotherapy with and without embolization in patients with hepatocellular carcinoma.
    Ikeda M; Maeda S; Shibata J; Muta R; Ashihara H; Tanaka M; Fujiyama S; Tomita K
    Oncology; 2004; 66(1):24-31. PubMed ID: 15031595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of hepatocellular carcinoma by transarterial approach].
    Luo PF
    Zhonghua Yi Xue Za Zhi; 1993 Mar; 73(3):158-60, 191. PubMed ID: 8391913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological and clinical studies on lipiodol emulsion for hepatocellular carcinoma].
    Kodama T; Arima K; Sakamoto H; Suga M; Yachi A
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2544-8. PubMed ID: 2843121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
    Maeda S; Shibata J; Fujiyama S; Tanaka M; Noumaru S; Sato K; Tomita K
    Hepatogastroenterology; 2003; 50(51):809-13. PubMed ID: 12828090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Volumetric and morphological CT parameters for assessing prognosis and treatment control in hepatocellular carcinoma undergoing arterial chemoembolization].
    Vogl TJ; Trapp M; Pegios W; Mack M; Bechstein WO; Keck W; Scholz A; Schröder H; Neuhaus P; Felix R
    Rofo; 1997 Sep; 167(3):219-26. PubMed ID: 9376548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma.
    Miraglia R; Pietrosi G; Maruzzelli L; Petridis I; Caruso S; Marrone G; Mamone G; Vizzini G; Luca A; Gridelli B
    World J Gastroenterol; 2007 Jun; 13(21):2952-5. PubMed ID: 17589945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter arterial embolization using iodized oil (lipiodol) mixed with an anticancer drug for the treatment of hepatocellular carcinoma.
    Ohishi H; Yoshimura H; Uchida H; Sakaguchi H; Yoshioka T; Ohue S; Matsui T; Takaya A; Tsujii T
    Cancer Chemother Pharmacol; 1989; 23 Suppl():S33-6. PubMed ID: 2538263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.